FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105578431> ?p ?o ?g. }

• W2105578431 abstract "Abstract Background Diminished expression or activity of prostate apoptosis response protein 4 (Par-4) has been demonstrated in a number of cancers, although reports on Par-4 expression during colon cancer progression are lacking. An understanding of the molecular events in conjunction with the genetic networks affected by Par-4 is warranted. Results Colon cancer specimens derived from patients have significantly diminished expression of Par-4 mRNA relative to paired normal colon. Hence, the functional consequences of reintroducing Par-4 into HT29 colon cancer cells were assessed. Overexpression augmented the interaction of Par-4 with NFκB in the cytosol but not nucleus, and facilitated apoptosis in the presence of 5-fluorouracil (5-FU). Analogous findings were obtained when AKT1 pro-survival signaling was inhibited. Transcriptome profiling identified ~700 genes differentially regulated by Par-4 overexpression in HT29 cells. Nearly all Par-4-regulated genes were shown by promoter analysis to contain cis -binding sequences for NFκB, and meta-analysis of patient expression data revealed that one-third of these genes exist as a recurrent co-regulated network in colon cancer specimens. Sets of genes involved in programmed cell death, cell cycle regulation and interestingly the microRNA pathway were found overrepresented in the network. Noteworthy, Par-4 overexpression decreased NFκB occupancy at the promoter of one particular network gene DROSHA , encoding a microRNA processing enzyme. The resulting down-regulation of DROSHA was associated with expression changes in a cohort of microRNAs. Many of these microRNAs are predicted to target mRNAs encoding proteins with apoptosis-related functions. Western and functional analyses were employed to validate several predictions. For instance, miR-34a up-regulation corresponded with a down-regulation of BCL2 protein. Treating Par-4-overexpressing HT29 cells with a miR-34a antagomir functionally reversed both BCL2 down-regulation and apoptosis by 5-FU. Conversely, bypassing Par-4 overexpression by direct knockdown of DROSHA expression in native HT29 cells increased miR-34a expression and 5-FU sensitivity. Conclusion Our findings suggest that the initiation of apoptotic sensitivity in colon cancer cells can be mediated by Par-4 binding to NFκB in the cytoplasm with consequential changes in the expression of microRNA pathway components." @default.
• W2105578431 created "2016-06-24" @default.
• W2105578431 creator A5001311093 @default.
• W2105578431 creator A5007967797 @default.
• W2105578431 creator A5014837432 @default.
• W2105578431 creator A5018443231 @default.
• W2105578431 creator A5029096739 @default.
• W2105578431 creator A5048579470 @default.
• W2105578431 creator A5049434103 @default.
• W2105578431 creator A5055087673 @default.
• W2105578431 creator A5060130177 @default.
• W2105578431 creator A5062031610 @default.
• W2105578431 creator A5073587598 @default.
• W2105578431 creator A5076992201 @default.
• W2105578431 creator A5087345379 @default.
• W2105578431 date "2010-04-30" @default.
• W2105578431 modified "2023-10-14" @default.
• W2105578431 title "Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NFκB and microRNA network" @default.
• W2105578431 cites W126084106 @default.
• W2105578431 cites W1486150850 @default.
• W2105578431 cites W1534346139 @default.
• W2105578431 cites W1964481452 @default.
• W2105578431 cites W1970657655 @default.
• W2105578431 cites W1972755526 @default.
• W2105578431 cites W1973004789 @default.
• W2105578431 cites W1979141644 @default.
• W2105578431 cites W1980269624 @default.
• W2105578431 cites W1996344228 @default.
• W2105578431 cites W1998206145 @default.
• W2105578431 cites W2001601360 @default.
• W2105578431 cites W2007662857 @default.
• W2105578431 cites W2008167035 @default.
• W2105578431 cites W2008652897 @default.
• W2105578431 cites W2011860098 @default.
• W2105578431 cites W2017972130 @default.
• W2105578431 cites W2021533617 @default.
• W2105578431 cites W2029604570 @default.
• W2105578431 cites W2031554805 @default.
• W2105578431 cites W2035213975 @default.
• W2105578431 cites W2038167014 @default.
• W2105578431 cites W2045472699 @default.
• W2105578431 cites W2046163031 @default.
• W2105578431 cites W2059073003 @default.
• W2105578431 cites W2059848983 @default.
• W2105578431 cites W2068536063 @default.
• W2105578431 cites W2069377495 @default.
• W2105578431 cites W2071126343 @default.
• W2105578431 cites W2074210527 @default.
• W2105578431 cites W2077845354 @default.
• W2105578431 cites W2079520714 @default.
• W2105578431 cites W2082937740 @default.
• W2105578431 cites W2086774759 @default.
• W2105578431 cites W2087763150 @default.
• W2105578431 cites W2087956326 @default.
• W2105578431 cites W2090396091 @default.
• W2105578431 cites W2096381270 @default.
• W2105578431 cites W2103173512 @default.
• W2105578431 cites W2107227406 @default.
• W2105578431 cites W2107277218 @default.
• W2105578431 cites W2109033574 @default.
• W2105578431 cites W2109155259 @default.
• W2105578431 cites W2110211384 @default.
• W2105578431 cites W2111655556 @default.
• W2105578431 cites W2117204059 @default.
• W2105578431 cites W2123830992 @default.
• W2105578431 cites W2125523949 @default.
• W2105578431 cites W2127053639 @default.
• W2105578431 cites W2127938920 @default.
• W2105578431 cites W2130317887 @default.
• W2105578431 cites W2134650984 @default.
• W2105578431 cites W2135030836 @default.
• W2105578431 cites W2142471892 @default.
• W2105578431 cites W2143296225 @default.
• W2105578431 cites W2144154026 @default.
• W2105578431 cites W2146542099 @default.
• W2105578431 cites W2149881105 @default.
• W2105578431 cites W2150696691 @default.
• W2105578431 cites W2151868278 @default.
• W2105578431 cites W2152091242 @default.
• W2105578431 cites W2156656429 @default.
• W2105578431 cites W2158266834 @default.
• W2105578431 cites W2166921147 @default.
• W2105578431 cites W2167395325 @default.
• W2105578431 cites W2168546553 @default.
• W2105578431 cites W2171791356 @default.
• W2105578431 cites W2321661916 @default.
• W2105578431 cites W2322768926 @default.
• W2105578431 cites W4237473415 @default.
• W2105578431 doi "https://doi.org/10.1186/1476-4598-9-98" @default.
• W2105578431 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2883962" @default.
• W2105578431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20433755" @default.
• W2105578431 hasPublicationYear "2010" @default.
• W2105578431 type Work @default.
• W2105578431 sameAs 2105578431 @default.
• W2105578431 citedByCount "54" @default.
• W2105578431 countsByYear W21055784312012 @default.
• W2105578431 countsByYear W21055784312013 @default.
• W2105578431 countsByYear W21055784312014 @default.
• W2105578431 countsByYear W21055784312015 @default.
• W2105578431 countsByYear W21055784312016 @default.

• next